Thursday, July 2, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
FDA CLEAREDLED Light Therapy Mask (K9C-TK, K9C-K, K9P-YK, K9P-K, FM-03BK, FM-09K) — Guangdong Newdermo Biotech Co., Ltd.2 weeks agoFDA CLEAREDVeineo System (00MEDRF4000TCUS 05CR45iT 06Pedal1St) — F Care Systems USA, LLC4 weeks agoFDA CLEAREDCoolSeal Generator® (CSL-200-90) — Hologic, Inc.2 weeks agoFDA CLEAREDMILAN System — Lumenis Be, Ltd.4 weeks agoFDA CLEAREDPICOSURE WORKSTATION — Cynosure, LLC2 weeks agoFDA CLEAREDCurrentBody Skin LED Multi Light Therapy Mask (MK-110D) — The Beauty Tech Group, Ltd.4 weeks agoFDA CLEAREDLED Neck Beauty Mask (ZLD-66A,ZLD-90E,ZLD-130,ZLD-180H) — Shenzhen Kaiyan Medical Equipment Co., Ltd.2 weeks agoFDA CLEAREDLumiGlam Laser System (SHE-LSP601-3) — Beijing Sano Laser S&T Development Co.,Ltd4 weeks agoFDA CLEAREDBarbed PDO Suture — Sutura Medical Technology, Inc.3 weeks agoFDA CLEAREDLipocosm Harmonic System — Lipocosm, LLC3 weeks agoFDA CLEAREDIntense Pulsed Light Therapy Device — Sanhe LEFIS Electronics Co., Ltd.3 weeks agoFDA CLEAREDERBECRYO 2 Cryosurgical Unit and Accessories — Erbe Elektromedizin GmbH3 weeks ago
Markets & Filings

S-1 / IPO Filing

The SEC registration a company files to go public, revealing financials and risks ahead of its IPO.

Also known as: Form S-1, Registration Statement

What it is
An S-1 is the registration statement a private company files with the SEC to sell shares to the public. It discloses financials, risk factors, and use of proceeds. Its filing marks the start of the IPO process, subject to SEC review.
What it does
An S-1 filing signals a coming supply of new stock and reveals a company's economics for the first time, moving comparable public peers and sector sentiment. IPO pricing and lockup expirations are downstream catalysts. Government shutdowns can stall SEC review.
The evidence
High-profile S-1 filings have moved publicly traded peers as investors reprice the sector and anticipate new supply.
Best for
Public comparables in the filer's sector; recent-IPO cohorts.
Pairs well with
8-k, government-shutdown, catalyst
Use cautiously with
A filing is not a completed IPO; deals get pulled or repriced, and peer reactions can reverse.
Cautions
Lockup expirations after the IPO can pressure the new stock and its peers.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

More markets & filings

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo →